Volume 124, Issue 5, Pages (May 2003)

Slides:



Advertisements
Similar presentations
Helicobacter pylori γ-Glutamyl Transpeptidase Is a Pathogenic Factor in the Development of Peptic Ulcer Disease  Min Gong, Samantha Shi Min Ling, Sook.
Advertisements

Volume 114, Issue 4, Pages (April 1998)
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 137, Issue 4, Pages (October 2009)
Volume 142, Issue 2, Pages (February 2012)
Volume 128, Issue 7, Pages (June 2005)
Y. Huang, X.-F. Tian, X.-G. Fan, C.-Y. Fu, C. Zhu 
Volume 145, Issue 5, Pages (November 2013)
Volume 137, Issue 4, Pages (October 2009)
Volume 116, Issue 6, Pages (June 1999)
Volume 14, Issue 6, Pages (February 2016)
Athena Kalyvas, Samuel David  Neuron 
Volume 137, Issue 4, Pages (October 2009)
Volume 145, Issue 5, Pages (November 2013)
Volume 122, Issue 1, Pages (January 2002)
Volume 132, Issue 3, Pages (March 2007)
Volume 141, Issue 5, Pages (November 2011)
Volume 140, Issue 2, Pages e7 (February 2011)
Helicobacter pylori cag-Type IV Secretion System Facilitates Corpus Colonization to Induce Precancerous Conditions in Mongolian Gerbils  Gabriele Rieder,
Volume 133, Issue 1, Pages e3 (July 2007)
Volume 134, Issue 5, Pages (May 2008)
The effect of bisphenol A (BPA) on colon and liver inflammation.
Prostaglandin E2 Prevents Helicobacter-Induced Gastric Preneoplasia and Facilitates Persistent Infection in a Mouse Model  Isabella M. Toller, Iris Hitzler,
Wendy Hall, Martin Buckley, Paul Crotty, Colm A O’Morain 
Volume 136, Issue 4, Pages (April 2009)
Volume 131, Issue 2, Pages (August 2006)
Volume 128, Issue 5, Pages (May 2005)
Volume 133, Issue 1, Pages e3 (July 2007)
Volume 142, Issue 5, Pages e6 (May 2012)
Volume 128, Issue 4, Pages (April 2005)
Volume 131, Issue 4, Pages (October 2006)
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 134, Issue 4, Pages (April 2008)
Volume 134, Issue 2, Pages (February 2008)
Volume 11, Issue 6, Pages (June 2012)
Volume 140, Issue 1, Pages (January 2011)
Volume 141, Issue 4, Pages e1 (October 2011)
Volume 114, Issue 4, Pages (April 1998)
Volume 132, Issue 7, Pages (June 2007)
Volume 151, Issue 6, Pages e3 (December 2016)
Volume 133, Issue 4, Pages (October 2007)
Volume 124, Issue 4, Pages (April 2003)
Volume 129, Issue 3, Pages (September 2005)
Volume 139, Issue 6, Pages (December 2010)
Shalmali J. Dharma, M. Sc. , Deepak N. Modi, Ph. D. , Tarala D
Volume 140, Issue 1, Pages e4 (January 2011)
Volume 125, Issue 6, Pages (December 2003)
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Volume 125, Issue 6, Pages (December 2003)
This Month in Gastroenterology
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 128, Issue 3, Pages (March 2005)
Volume 128, Issue 7, Pages (June 2005)
Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6- dependent mechanism1   Anil Mishra, Marc E Rothenberg  Gastroenterology 
Silvina Gazzaniga, Alicia Bravo, Silvana R
Volume 14, Issue 5, Pages (November 2008)
Volume 72, Issue 3, Pages (August 2007)
Volume 131, Issue 6, Pages (December 2006)
Volume 126, Issue 1, Pages (January 2004)
Volume 119, Issue 3, Pages (September 2000)
Volume 2, Issue 3, Pages (September 2002)
Volume 125, Issue 4, Pages (October 2003)
Aiden C.J. Marshall, Frank Alderuccio, Ban-Hock Toh  Gastroenterology 
Volume 114, Issue 4, Pages (April 1998)
Volume 127, Issue 2, Pages (August 2004)
Volume 123, Issue 4, Pages (October 2002)
Volume 125, Issue 6, Pages (December 2003)
Volume 121, Issue 3, Pages (September 2001)
Volume 124, Issue 7, Pages (June 2003)
Helicobacter pylori and Gastric Cancer: A New Paradigm For Inflammation-Associated Epithelial Cancers  JeanMarie Houghton, Timothy C. Wang  Gastroenterology 
Presentation transcript:

Volume 124, Issue 5, Pages 1408-1419 (May 2003) Chronic Helicobacter pylori infections induce gastric mutations in mice1   Eliette Touati, Valérie Michel, Jean-Michel Thiberge, Nicole Wuscher, Michel Huerre, Agnès Labigne  Gastroenterology  Volume 124, Issue 5, Pages 1408-1419 (May 2003) DOI: 10.1016/S0016-5085(03)00266-X

Figure 1 Anti-H. pylori and anti-H. felis antibodies in the sera of C57BL/6 Big Blue mice infected with H. pylori SS1 (gray circles) and H. felis CS1 (closed circles), respectively, or noninfected (open circles) detected by enzyme-linked immunosorbent assay. The results are presented as A405–492 readings for diluted serum samples (1:100). Each point corresponds to one mouse. Horizontal bars represent the mean value in each condition for mice 1, 3, 6, 9, and 12 months after infection. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 2 Lesions of the antral mucosa of (C-H2) H. pylori- and (I-K2) H. felis-infected mice compared with (A and B) uninfected mice. In contrast to the normal glandular architecture of uninfected tissues (A and B; original magnification 100×), the gastric glands infected by H. pylori for (C and D) 6 and (F and G) 12 months and H. felis for (I) 6 and (J) 12 months are hyperplastic. Inflammatory infiltrates are seen by H&E staining in both (C and F) H. pylori- and (I and J) H. felis-infected samples, in the lamina propria and within the submucosa, as indicated by the arrows (bar = 150 μm). Polymorphonuclear cells are visible (E2) around and (H2 and I [inset]) inside the glands, as indicated by the arrowheads (bar = 37.5 μm). Note the large aggregates of lymphocytes (arrows in J and inset) and polymorphonuclear cells (arrowhead in J and inset) seen after 12 months of H. felis infection. These changes are accompanied by (D and G) an increase in the number of mucus-producing cells (periodic acid-Schiff stain indicated by the arrows) compared with (B) control (bar = 150 μm). The Warthin-Starry stains of (E1 and H1) H. pylori- and (K1 and K2) H. felis-infected samples show the presence of bacteria inside the glands at (E1 and K1) 6 and (H1 and K2) 12 months after infection as indicated by the arrows (bar =15 μm). Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 3 Inflammation grading in long-term H. pylori- (gray symbols) and H. felis- (hatched symbols) infected and uninfected mice (open symbols) after (A) 6 months and (B) 12 months. The intensity of the lesions was evaluated semiquantitatively.36 Infiltrates of polymorphonuclear cells (PMN) and plasmocytes were graded as follows: 0, no infiltrates; 1, mild, multifocal infiltration; 2, mild, widespread infiltration; 3, mild, widespread, and moderate multifocal infiltration; 4, moderate, widespread infiltration; 5, moderate, widespread, and severe multifocal infiltration. Lymphoid aggregates were graded as 1 (mild, 1–10 glands), 2 (moderate, 10–20 glands), or 3 (severe, more than 20 glands). Each symbol corresponds to one mouse. The horizontal bars represent the mean scores, of which the values are reported in parentheses. No significant differences for PMN infiltrates, plasmocyte infiltrates, and lymphocyte aggregates were observed between H. pylori and H. felis time-matched infected mice (P > 0.05). Circles, antrum; squares, corpus. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 4 iNOS immunohistochemistry in gastric tissue sections of (A) noninfected, (B) H. felis CS1-, and (C) H. pylori SS1-infected samples at 6 months. Strong immunoreactivity for iNOS can be observed limited to the inflammatory cell infiltrate in the mucosa and deep mucosa in all infected samples. Note that there is weak iNOS immunoreactivity in epithelial cells in the case of H. felis infection (B). Uninfected samples were either negative or, when positive, only a very small number of iNOS-producing cells were detected in the lamina propria. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 5 RT-PCR analysis of iNOS mRNA in stomach mucosa from Big Blue mice. (A) Representative gel of iNOS and β-actin expression in samples from uninfected, H. pylori SS1-, and H. felis CS1-infected mice after 6 and 12 months. (B) Histograms corresponding to the quantification of the relative expression of iNOS vs. β-actin after 6 and 12 months. P values are indicated for significant differences between infected and uninfected samples. Each column represents the mean ± SD for one group of mice (n = 6 or 7) for each tested condition. Each experiment was performed 3 times. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 6 Gastric mutant frequencies measured using the Big Blue assay protocol29,31 in the stomach of age-matched uninfected and H. pylori- or H. felis-infected mice on the standard diet (open circles) and on the high-salt diet (closed circles) after 6 and 12 months. Each point corresponds to one mouse. Reported values are the mean gastric mutant frequency (× 10−5) for each group of mice. The positive control for the mutagenesis assay was Big Blue mice treated with the reference mutagen, R7000 (see Materials and Methods); the gastric mutant frequency 3 weeks after treatment was 30 ± 11 × 10−5, and that for the corresponding untreated mice was 6.7 ± 2 × 10−5. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)

Figure 7 Distribution of the base pair substitution events in the cII gene as assessed using mutants isolated from the genomic gastric DNA from (A and C) uninfected and (B and D) H. pylori-infected mice after (A and B) 6 months and (C and D) 12 months. The number of each type of base pair substitution is expressed as a percentage of all substitution events observed. Gastroenterology 2003 124, 1408-1419DOI: (10.1016/S0016-5085(03)00266-X)